Form 4 Tracker
Gary D Glick

Director, President and Chief Executive Officer · 1 filing · Latest: May 7, 2026

Odyssey Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
ODTX
Gary D GlickDirector, President and Chief Executive OfficerMay 11, 2026
Conversion
27,386415,973